RKD

MDM Fundraising Joining RKD Group, Becoming Foremost Solutions Provider to Missions

Retrieved on: 
星期三, 五月 8, 2024
MDM, SVP, Organization, Growth, RKD, Organic

"MDM joining RKD is truly exciting for our Missions clients and the broader Citygate Network," said Chris Pritcher, CEO at RKD Group.

Key Points: 
  • "MDM joining RKD is truly exciting for our Missions clients and the broader Citygate Network," said Chris Pritcher, CEO at RKD Group.
  • "RKD has always been deeply committed to the success of Rescue Missions, built on the legacy of Missions fundraising giants like Ron Davis, Tim Kersten and others.
  • This strategic alliance allows the two organizations to become the foremost audience-first fundraising solutions provider to missions in North America.
  • MDM Fundraising, an RKD Group company, will operate as a subsidiary of RKD and continue to serve their nearly 50 faith-based clients with robust, Christian fundraising solutions offerings.

Introducing a New Destination for the Rare Kidney Disease Community

Retrieved on: 
星期一, 五月 6, 2024
Kidney disease, Kidney, Patient, Collection, Research, Physician, Connect, Caregiver, RKD, Pharmaceutical industry

The revamped online platform serves as a pivotal hub of information and home for all individuals and families affected by rare, protein-spilling kidney diseases.

Key Points: 
  • The revamped online platform serves as a pivotal hub of information and home for all individuals and families affected by rare, protein-spilling kidney diseases.
  • NephCure, a leading nonprofit organization dedicated to rare kidney disease, announces new website.
  • With more than 20 years of dedication to the entire rare kidney disease (RKD) community, NephCure has meticulously crafted the new NephCure.org to serve as a comprehensive and user-friendly destination.
  • The launch of the updated NephCure.org comes at a pivotal time when advancements in research and treatment options for rare, protein-spilling kidney disease are rapidly evolving.

RKD Group Acquires Heller Consulting to Provide End-to-End Technology and Strategic Solutions

Retrieved on: 
星期三, 五月 1, 2024
Marketing, Acquisition, Organization, Growth, RKD, Management

DALLAS, May 1, 2024 /PRNewswire/ -- RKD Group announced today the acquisition of Heller Consulting, a leading strategy, planning and implementation provider for nonprofit technology.

Key Points: 
  • DALLAS, May 1, 2024 /PRNewswire/ -- RKD Group announced today the acquisition of Heller Consulting, a leading strategy, planning and implementation provider for nonprofit technology.
  • Heller Consulting brings three decades of expertise in systems design and implementation to RKD Group's existing fundraising and marketing solutions.
  • Operating as a subsidiary of RKD Group, Heller Consulting will continue to help nonprofit organizations understand and find solutions for their specific technology challenges.
  • Founder Keith Heller will remain on board as a strategic advisor, and Jeffery Appell will serve as President of Heller Consulting, an RKD Group company.

RKD Group Announces Promotions and Leadership Additions

Retrieved on: 
星期一, 四月 15, 2024
Food bank, Tonie, Animal welfare, Partnership, Culture, Senior, Product management, RKD, Trust, Marketing, Creative director, Nate, Growth, Management

DALLAS, April 15, 2024 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider in North America, recently announced new promotions and additions to its industry-leading team.

Key Points: 
  • DALLAS, April 15, 2024 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider in North America, recently announced new promotions and additions to its industry-leading team.
  • "These are truly special moments in our company that deserve to be celebrated," said Chris Pritcher, CEO at RKD Group.
  • In addition to these promotions, RKD is thrilled to welcome Nate Beran as Vice President of Product Management.
  • "Their leadership and unique perspectives will enable our clients to accelerate their growth as RKD propels the practice of philanthropy to new heights."

RKD Group Reinforces Client Experience, Purpose in Latest Leadership Moves

Retrieved on: 
星期五, 三月 8, 2024
SVP, Marketing, Growth, RKD, Human, Sconyers Bar-B-Que, Acceleration, Management

DALLAS, March 8, 2024 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider to nonprofits in North America, announced its latest leadership moves.

Key Points: 
  • DALLAS, March 8, 2024 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider to nonprofits in North America, announced its latest leadership moves.
  • "At our core, we are dedicated to amplifying and championing the missions of the clients we serve," said Chris Pritcher, CEO at RKD Group.
  • Dawn Beall, SVP of Client Engagement, has taken on a new role in RKD's client experience team, focused on enhancing the voice of the client throughout the entire client journey, from onboarding to proactive engagement and support.
  • Ellen Roeder has joined RKD as VP of Client Partnership, strengthening how RKD is transitioning clients from cooperative channel marketing to omnichannel donor experience.

RKD Group is Proud To Share The Latest Senior Leader Additions And Promotions

Retrieved on: 
星期三, 一月 31, 2024
Growth, Senior, RKD, AI, Acceleration, Mission, Strategy, Data science, Marketing, Side platform, Mouth, Culture, Management

DALLAS, Jan. 31, 2024 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider to nonprofits in North America, announces additions and promotions to its leadership team.

Key Points: 
  • DALLAS, Jan. 31, 2024 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider to nonprofits in North America, announces additions and promotions to its leadership team.
  • These additions emphasize RKD Group's commitment to client experience, transformational results and continued growth.
  • "The recognition of these three talented professionals underscores our commitment to our clients and giving them the best, most thoughtful, most forward-looking approach possible," said Chris Pritcher, CEO at RKD Group.
  • "I am thrilled to be a part of such a dynamic and diverse team with a deep commitment to nonprofit growth.

Vidya Chadaga Joins RKD Group as Executive Vice President of Products

Retrieved on: 
星期四, 五月 11, 2023
IBM, Software as a service, Marketing, GE, SAP, Oracle, Vidya, RKD, ServiceMax, Management, Marketo, Adobe

DALLAS, May 11, 2023 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider to nonprofits in North America, is thrilled to welcome Vidya Chadaga as Executive Vice President of Products.

Key Points: 
  • DALLAS, May 11, 2023 /PRNewswire/ -- RKD Group, the leading fundraising and marketing solutions provider to nonprofits in North America, is thrilled to welcome Vidya Chadaga as Executive Vice President of Products.
  • Chadaga is a skilled product strategist, technology expert and empathetic leader with more than two decades of experience in bringing innovative products to market.
  • "Vidya will be instrumental in our efforts to develop products that enable our nonprofit partners to reimagine their fundraising in this age of connection."
  • Chadaga will join RKD's executive committee, helping to build innovative solutions that solve the industry's biggest problems.

Travere Therapeutics Announces Topline Results from Two-Year Primary Efficacy Endpoint in Pivotal Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

Retrieved on: 
星期一, 五月 1, 2023
Kidney failure, CMA, Prevalence, Jay Traver, European Medicines Agency, New Drug Application, EGFR, CSL Vifor, Immunoglobulin A, EMA, Proteinuria, Kidney disease, Conditional, IgA nephropathy, Shanda, Patient, Focal segmental glomerulosclerosis, RKD, SAN, Kidney, Therapy, Caregiver, Pharmaceutical industry, Medical imaging, FSGS, Irbesartan

SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) --  Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced topline primary efficacy results from the pivotal Phase 3 DUPLEX Study of sparsentan, a Dual Endothelin Angiotensin Receptor Antagonist (DEARA), in focal segmental glomerulosclerosis (FSGS).

Key Points: 
  • SAN DIEGO, May 01, 2023 (GLOBE NEWSWIRE) --  Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced topline primary efficacy results from the pivotal Phase 3 DUPLEX Study of sparsentan, a Dual Endothelin Angiotensin Receptor Antagonist (DEARA), in focal segmental glomerulosclerosis (FSGS).
  • After 108 weeks of treatment, sparsentan achieved a mean reduction in proteinuria from baseline of 50%, compared to 32% for irbesartan.
  • Results from the two-year analysis demonstrated that sparsentan was well-tolerated and has shown a comparable safety profile to irbesartan.
  • The secondary and topline exploratory endpoints, including renal outcomes, trended favorably for sparsentan in the study.

NephCure Joins Enon Tabernacle's Men's Health Initiative

Retrieved on: 
星期三, 四月 19, 2023
Blood pressure, University, Health education, APOL1, Urine, Kidney disease, Cholesterol, African Americans, Pastor, Video, Boehringer Ingelheim, RKD, Risk, Cancer, Platinum Partners, Health, FDA, Therapy, Labcorp, Mental health, Men's Health, Mallinckrodt, Prostate cancer, Pharmaceutical industry, Church

KING OF PRUSSIA, Pa., April 19, 2023 /PRNewswire/ -- NephCure, a nonprofit focused on finding better treatments and a cure for rare kidney disease (RKD), is partnering with Enon Tabernacle Baptist Church as they host their 12th annual "Men Know Your Numbers" health education and screening event on April 22 from 8 a.m. to 6 p.m ET.

Key Points: 
  • During the event, the Church, located at 2800 W. Cheltenham Ave. in Mount Airy, transforms their house of worship into a men's health and wellness clinic.
  • This year, NephCure is working with the University of Pennsylvania chapter of the Kidney Disease Screening and Awareness Program to offer on-site urine screening for kidney disease.
  • The event with Enon Tabernacle also serves as the kick-off of NephCure's RKD Screening Campaign, an ongoing effort to provide kidney disease education and screening opportunities in targeted locations nationwide.
  • NephCure is proud to recognize Travere Therapeutics as a Platinum Partner of NephCure's RKD Screening Campaign.

Interim Analysis of the Phase 3 PROTECT Study of FILSPARI™ (Sparsentan) in IgA Nephropathy Presented by Travere Therapeutics at NKF Spring Clinical Meetings

Retrieved on: 
星期四, 四月 13, 2023
CT, Kidney failure, Heart Protection Study, Immunoglobulin A, Proteinuria, IgA nephropathy, Nephrology, Patient, RKD, Division, NKF, National Kidney Foundation, University Center, Therapy, PROTECT, Kidney disease, Safety, Pharmaceutical industry, Irbesartan

Data demonstrates a significant and clinically meaningful anti-proteinuric effect of Sparsentan compared to Irbesartan.

Key Points: 
  • Data demonstrates a significant and clinically meaningful anti-proteinuric effect of Sparsentan compared to Irbesartan.
  • "The data also highlight a consistent treatment effect across patient populations, regardless of age, race, gender, clinical characteristics, and concomitant medications."
  • Data from the study were recently published in The Lancet and announced by Travere Therapeutics.
  • Thousands of kidney care professionals will attend the Spring Clinical Meetings in-person and virtually.